SCHEMBL3846334

SCHEMBL3846334

Fc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2cc(Cl)c3ncc(I)n3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
SRC P12931 2/20 0.34
BRAF P15056 2/20 0.34
KDR P35968 2/20 0.34
LMNA P02545 2/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP2C19 P33261 1/20 0.33
RECQL P46063 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
TP53 P04637 1/20 0.32
PTGS2 P35354 2/20 0.32
CSNK1D P48730 3/20 0.32
CSNK1E P49674 3/20 0.32
MAPK13 O15264 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845235 0.91 SMN1; SMN2 (0.34) SMN1; SMN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL3847945 0.90 SMN1; SMN2 (0.34) SMN1; SMN2SRCBRAFKDRCYP1A2
SCHEMBL3848664 0.89 PTGS2 (0.32) SMN1; SMN2SRCBRAFKDRPTGS2
SCHEMBL3847277 0.84 SMN1; SMN2 (0.36) SMN1; SMN2SRCBRAFKDRLMNA
SCHEMBL3845976 0.83 TGFBR1 (0.40) MAPK14
SCHEMBL3846336 0.83 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL3846052 0.82 KDR (0.37) SMN1; SMN2SRCBRAFKDRCSNK1D
SCHEMBL3850113 0.80 SMN1; SMN2 (0.38) SMN1; SMN2SRCBRAFKDRLMNA
SCHEMBL3844953 0.76 MET (0.36) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL3845238 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed